NRP/B mutations impair Nrf2-dependent NQO1 induction in human primary brain tumors

S Seng1, H K Avraham, G Birrane

  • 1Division of Experimental Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.

Oncogene
|November 5, 2008
PubMed

Insights

Nuclear restricted protein in brain (NRP/B) interacts with Nrf2 to regulate antioxidant gene expression. Mutations in NRP/B disrupt this interaction, leading to its cytoplasmic localization and impaired cellular protection in brain tumors.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Neuro-oncology

Background:

  • Brain tumors involve genetic alterations and oxidative stress from reactive oxygen species (ROS).
  • Nuclear restricted protein in brain (NRP/B) is a nuclear matrix protein implicated in cellular processes.
  • NF-E2-related factor 2 (Nrf2) is a key transcription factor regulating antioxidant responses.

Purpose of the Study:

  • To investigate the role of NRP/B in the cellular response to oxidative stress in brain tumors.
  • To elucidate the interaction between NRP/B and Nrf2 in regulating antioxidant gene expression.
  • To determine the impact of NRP/B mutations and localization on brain tumor development.

Main Methods:

  • Co-localization and interaction studies of NRP/B and Nrf2 in SH-SY5Y cells under oxidative stress.
  • Analysis of NAD(P)H:quinone oxidoreductase 1 (NQO1) expression.
  • Examination of NRP/B localization in normal brain cells versus primary brain tumors.
  • Functional analysis of NRP/B mutants from brain tumors.

Main Results:

  • NRP/B expression and its interaction with Nrf2 are upregulated during oxidative stress.
  • NRP/B-Nrf2 association is critical for the induction of NQO1.
  • NRP/B is predominantly nuclear in normal brain cells but cytoplasmic in brain tumors.
  • Mutant NRP/B from brain tumors exhibits cytoplasmic localization and fails to induce Nrf2-dependent NQO1 transcription.

Conclusions:

  • NRP/B mutations and altered cytoplasmic localization disrupt Nrf2-dependent NQO1 activation in brain tumors.
  • Dysregulation of NRP/B function contributes to impaired cellular protection against ROS in brain tumorigenesis.
  • This study reveals a novel mechanism involving NRP/B in modulating Nrf2-mediated antioxidant defense in the brain.

Related Concept Videos

The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...